[Continued clinical studies on the question of toxicity of prolonged administrations of cyclamate in the patients with liver and kidney diseases].
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins / Q000032:analysis; D001806:Blood Urea Nitrogen; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000503:physiopathology*; D007677:Kidney Function Tests; D008107:Liver Diseases / Q000201:enzymology / Q000503:physiopathology*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012964:Sodium / Q000008:administration & dosage / Q000633:toxicity; D013448:Sulfobromophthalein; D013549:Sweetening Agents / Q000008:administration & dosage / Q000633:toxicity*; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000503:physiopathology; D014557:Urobilin / Q000652:urine
D001798:Blood Proteins; D010919:Placebos; D013549:Sweetening Agents; D013448:Sulfobromophthalein; D014557:Urobilin; D002784:Cholesterol; D012964:Sodium; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin
Fortgesetzte klinische Untersuchungen zur Frage der Toxizität langfristiger Gaben von Cyclamat bei Patienten mit Leber- und Nierenkrankheiten.